0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Pharmacogenetics/Pharmacogenomics
 1-20 of 28 Articles
JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(12):1192. doi:10.1001/jama.2014.3085.

JAMA | 
Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

JAMA | 
Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

JAMA Ophthalmology | 
Original Investigation | 
Megan M. McLaughlin, MS; Marcella G. Paglione, PharmD; Jason Slakter, MD; et al.
JAMA Ophthalmol. 2013;131(12):1595-1601. doi:10.1001/jamaophthalmol.2013.5002.

JAMA Dermatology | 
Case Report/Case Series | 
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.
JAMA Dermatol. 2013;149(12):1403-1406. doi:10.1001/jamadermatol.2013.8198.

JAMA Psychiatry | 
Original Investigation | 
Giuseppe Blasi, MD, PhD; Caterina De Virgilio, PhD; Apostolos Papazacharias, MD; et al.
JAMA Psychiatry. 2013;70(9):921-930. doi:10.1001/jamapsychiatry.2013.1378.
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Marc Julià, MD; Antonio Guilabert, MD; Francisco Lozano, MD; et al.
JAMA Dermatol. 2013;149(9):1033-1039. doi:10.1001/jamadermatol.2013.4632.

JAMA | 
Viewpoint | 
Jacob Doll, MD; Emily Zeitler, MD; Richard Becker, MD
JAMA. 2013;310(2):145-146. doi:10.1001/jama.2013.7155.

JAMA Psychiatry | 
Original Article | 
Andrew E. Timms, PhD; Michael O. Dorschner, PhD; Jeremy Wechsler, MS; et al.
JAMA Psychiatry. 2013;70(6):582-590. doi:10.1001/jamapsychiatry.2013.1195.
Includes: Supplemental Content

JAMA Neurology | 
Neurological Review | 
Shoji Tsuji, MD, PhD
JAMA Neurol. 2013;70(6):689-694. doi:10.1001/jamaneurol.2013.734.
Includes: CME

JAMA | 
Special Communication | 
Bruce R. Korf, MD, PhD; Heidi L. Rehm, PhD
JAMA. 2013;309(14):1511-1521. doi:10.1001/jama.2013.3239.
Includes: CME

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(1):20. doi:10.1001/jama.2012.173440.

JAMA | 
Viewpoint | 
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH
JAMA. 2012;307(18):1921-1922. doi:10.1001/jama.2012.3516.

JAMA | 
Editorial | 
Steven E. Nissen, MD
JAMA. 2011;306(24):2727-2728. doi:10.1001/jama.2011.1865.

JAMA | 
Commentary | 
Amber L. Beitelshees, PharmD, MPH; David L. Veenstra, PharmD, PhD
JAMA. 2011;306(11):1252-1253. doi:10.1001/jama.2011.1343.

JAMA | 
Commentary | 
David A. Mrazek, MD, FRCPsych; Caryn Lerman, PhD
JAMA. 2011;306(3):304-305. doi:10.1001/jama.2011.1010.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2010;304(16):1777. doi:10.1001/jama.2010.1490.

JAMA | 
Editorial | 
Deepak L. Bhatt, MD, MPH
JAMA. 2009;302(8):896-897. doi:10.1001/jama.2009.1249.

JAMA Dermatology | 
Editorial | 
Stephen E. Wolverton, MD
Arch Dermatol. 2009;145(6):707-710. doi:10.1001/archdermatol.2009.95.

JAMA Neurology | 
Original Contribution |  FREE
Esther Byun, MD; Stacy J. Caillier, BSc; Xavier Montalban, MD; et al.
Arch Neurol. 2008;65(3):337-344. doi:10.1001/archneurol.2008.47.
Includes: CME

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal
From The JAMA Network
JAMA
Health Agencies Update  | 
Public-Private Groups Seek Drug Targets
Bridget M. Kuehn, MSJ
JAMA
Viewpoint  | 
The Accelerated Approval of Oncologic Drugs:  Lessons From Ponatinib
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA
Medical News & Perspectives  | 
Another Novel Oral Anticoagulant Matches Warfarin
Mike Mitka, MSJ
JAMA Dermatology
Case Report/Case Series  | 
Identification of a Novel Complex BRAF Mutation Associated With Major Clinical Response to Vemurafenib in a Patient With Metastatic Melanoma
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.